Erasca, Inc. (ERAS)
13.61
-0.61
(-4.29%)
USD |
NASDAQ |
Nov 20, 16:00
13.74
+0.13
(+0.96%)
After-Hours: 20:00
Erasca Total Assets (Quarterly) : 998.94M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 998.94M |
| June 30, 2026 | 435.05M |
| March 31, 2026 | 461.23M |
| December 31, 2025 | 407.46M |
| September 30, 2025 | 420.40M |
| June 30, 2025 | 445.39M |
| March 31, 2025 | 471.24M |
| December 31, 2024 | 502.53M |
| September 30, 2024 | 528.90M |
| June 30, 2024 | 525.74M |
| March 31, 2024 | 370.02M |
| December 31, 2023 | 395.30M |
| Date | Value |
|---|---|
| September 30, 2023 | 419.41M |
| June 30, 2023 | 440.66M |
| March 31, 2023 | 467.54M |
| December 31, 2022 | 514.91M |
| September 30, 2022 | 446.43M |
| June 30, 2022 | 444.82M |
| March 31, 2022 | 475.47M |
| December 31, 2021 | 501.42M |
| September 30, 2021 | 521.95M |
| June 30, 2021 | 210.38M |
| March 31, 2021 | 224.63M |
| December 31, 2020 | 124.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Twist Bioscience Corp. | 1.122B |
| Revolution Medicines, Inc. | 4.304B |
| Immunome, Inc. | 505.53M |
| Tango Therapeutics, Inc. | 1.033B |
| Oncolytics Biotech, Inc. | 5.832M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 82.20M |
| Shareholders Equity (Quarterly) | 916.74M |
| Debt to Equity Ratio | 0.0473 |
| Current Ratio | 14.89 |
| Net Debt Paydown Yield | 0.02% |